CD8A and neoplasm: In particular, LID + US enhanced tumor growth inhibition and activation of innate immune cells such as dendritic cells in the tumor and tumor-draining lymph nodes, and promoted infiltration of CD8 + T cells in the tumor compared with LD and LI + US (Fig. 5d–k).